{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:16:33Z","timestamp":1740460593216,"version":"3.37.3"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bioorg.2025.108157","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T01:16:37Z","timestamp":1736471797000},"page":"108157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Activation of the 20S proteasome as a possible strategy to counteract amylin oligomerization in type 2 diabetes"],"prefix":"10.1016","volume":"155","author":[{"given":"Daria","family":"Sowik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Gi\u017cy\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Trepczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Witkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2025.108157_b0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1172\/JCI10761","article-title":"Interactions between insulin resistance and insulin secretion in the development of glucose intolerance","volume":"106","author":"Cavaghan","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108157_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-291X(91)91325-7","article-title":"Co-secretion of amylin and insulin from cultured islet beta-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents","volume":"179","author":"Moore","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2025.108157_b0015","first-page":"108","article-title":"The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus","author":"Kahn","year":"2000","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108157_b0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJM200008103430607","article-title":"Islet amyloid and type 2 diabetes mellitus","volume":"343","author":"H\u00f6ppener","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108157_b0025","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108157_b0030","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1021\/acs.molpharmaceut.7b01009","article-title":"Inhibition of human amylin aggregation and cellular toxicity by lipoic acid and ascorbic acid","volume":"15","author":"Azzam","year":"2018","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108157_b0035","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","article-title":"The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles","volume":"48","author":"Janson","year":"1999","journal-title":"Diabetes"},{"issue":"13","key":"10.1016\/j.bioorg.2025.108157_b0040","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","article-title":"Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108157_b0045","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1006\/jmbi.1999.3286","article-title":"Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin","volume":"294","author":"Nilsson","year":"1999","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108157_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chemphyslip.2009.03.008","article-title":"Membrane permeabilization by islet amyloid polypeptide","volume":"160","author":"Engel","year":"2009","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bioorg.2025.108157_b0055","doi-asserted-by":"crossref","DOI":"10.1038\/srep21274","article-title":"Pancreatic \u03b2-cell membrane fluidity and toxicity induced by human islet amyloid polypeptide species","volume":"6","author":"Pilkington","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108157_b0060","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.febslet.2013.01.046","article-title":"Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity","volume":"587","author":"Cao","year":"2013","journal-title":"FEBS Lett."},{"issue":"18","key":"10.1016\/j.bioorg.2025.108157_b0065","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89590","article-title":"\u03b2 Cell-specific increased expression of calpastatin prevents diabetes induced by islet amyloid polypeptide toxicity","volume":"1","author":"Gurlo","year":"2016","journal-title":"JCI Insight"},{"issue":"47","key":"10.1016\/j.bioorg.2025.108157_b0070","doi-asserted-by":"crossref","first-page":"36621","DOI":"10.1074\/jbc.M006170200","article-title":"Degradation of amylin by insulin-degrading enzyme","volume":"275","author":"Bennett","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108157_b0075","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1007\/s00125-012-2678-y","article-title":"Degradation of islet amyloid polypeptide by neprilysin","volume":"55","author":"Guan","year":"2012","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108157_b0080","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.2337\/db07-0178","article-title":"Impairment of the ubiquitin-proteasome pathway is a downstream endoplasmic reticulum stress response induced by extracellular human islet amyloid polypeptide and contributes to pancreatic beta-cell apoptosis","volume":"56","author":"Casas","year":"2007","journal-title":"Diabetes"},{"issue":"17","key":"10.1016\/j.bioorg.2025.108157_b0085","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1042\/BCJ20160026","article-title":"Proteasome regulates turnover of toxic human amylin in pancreatic cells","volume":"473","author":"Singh","year":"2016","journal-title":"Biochem. J."},{"issue":"37","key":"10.1016\/j.bioorg.2025.108157_b0090","doi-asserted-by":"crossref","first-page":"14210","DOI":"10.1074\/jbc.RA118.002414","article-title":"Functional proteasome complex is required for turnover of islet amyloid polypeptide in pancreatic \u03b2-cells","volume":"293","author":"Chatterjee Bhowmick","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108157_b0095","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41467-018-03509-0","article-title":"A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers","volume":"9","author":"Thibaudeau","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108157_b0100","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.molcel.2007.06.033","article-title":"Docking of the proteasomal ATPases' carboxyl termini in the 20S proteasome's alpha ring opens the gate for substrate entry","volume":"27","author":"Smith","year":"2007","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108157_b0105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.molcel.2005.04.016","article-title":"The 1.9 A structure of a proteasome-11S activator complex and implications for proteasome-PAN\/PA700 interactions","volume":"18","author":"F\u00f6rster","year":"2005","journal-title":"Mol. Cell"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108157_b0110","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2174\/1567205011666141107124538","article-title":"Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease","volume":"11","author":"Fawver","year":"2014","journal-title":"Curr. Alzheimer Res."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108157_b0115","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.neurobiolaging.2008.08.019","article-title":"Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes","volume":"31","author":"Miklossy","year":"2010","journal-title":"Neurobiol. Aging."},{"key":"10.1016\/j.bioorg.2025.108157_b0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-59259-888-5_6","article-title":"Neurotoxicity of the Alzheimer\u2019s \u03b2-amyloid peptide","author":"Howlett","year":"2005","journal-title":"Bioimag. Neurodegener."},{"key":"10.1016\/j.bioorg.2025.108157_b0125","doi-asserted-by":"crossref","unstructured":"Martinez-Valbuena I, Valenti-Azcarate R, Amat-Villegas I, et al. Amylin as a potential link between type 2 diabetes and Alzheimer disease. Ann. Neurol. 2019;86(4):539-551. doi:10.1002\/ana.25570Z. Arvanitakis et al., \u2018Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function\u2019, Arch. Neurol., 61 (2004) 661\u2013666.","DOI":"10.1002\/ana.25570"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108157_b0130","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archneur.61.5.661","article-title":"Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function","volume":"61","author":"Arvanitakis","year":"2004","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108157_b0135","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jmb.2008.11.006","article-title":"Molecular mechanism of thioflavin-T binding to the surface of beta-rich peptide self-assemblies","volume":"385","author":"Biancalana","year":"2009","journal-title":"J. Mol. Biol."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108157_b0140","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3390\/biom11121789","article-title":"Advances in proteasome enhancement by small molecules","volume":"11","author":"George","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108157_b0145","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1038\/s41598-017-05997-4","article-title":"Crystal structure of a low molecular weight activator Blm-pep with yeast 20S proteasome - insights into the enzyme activation mechanism","volume":"7","author":"Witkowska","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108157_b0150","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1021\/acs.jmedchem.8b01025","article-title":"Proline- and arginine-rich peptides as flexible allosteric modulators of human proteasome activity","volume":"62","author":"Gi\u017cy\u0144ska","year":"2019","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108157_b0155","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3390\/biom12060777","article-title":"Peptidomimetics based on C-terminus of Blm10 stimulate human 20S proteasome activity and promote degradation of proteins","volume":"12","author":"Ceka\u0142a","year":"2022","journal-title":"Biomolecules"},{"issue":"23","key":"10.1016\/j.bioorg.2025.108157_b0160","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abk2252","article-title":"Genetic and pharmacologic proteasome augmentation ameliorates Alzheimer's-like pathology in mouse and fly APP overexpression models","volume":"8","author":"Chocron","year":"2022","journal-title":"Sci. Adv."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108157_b0165","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.3390\/ijms25094663","article-title":"Rpt5-derived analogs stimulate human proteasome activity in cells and degrade proteins forming toxic aggregates in age-related diseases","volume":"25","author":"Ceka\u0142a","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108157_b0170","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"Suppl 1","key":"10.1016\/j.bioorg.2025.108157_b0175","first-page":"S67","article-title":"Molecular mechanisms of amyloid oligomers toxicity","volume":"33","author":"Kayed","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108157_b0180","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/0929866043407174","article-title":"Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration","volume":"11","author":"Walsh","year":"2004","journal-title":"Protein Pept. Lett."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108157_b0185","article-title":"Proteasome composition and activity changes in cultured fibroblasts derived from mucopolysaccharidoses patients and their modulation by genistein","volume":"20","author":"Pierzynowska","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108157_b0190","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0006-291X(03)00809-X","article-title":"Selective degradation of oxidatively modified protein substrates by the proteasome","volume":"305","author":"Grune","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:39:32Z","timestamp":1740379172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":38,"alternative-id":["S0045206825000379"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108157","relation":{},"ISSN":["0045-2068"],"issn-type":[{"type":"print","value":"0045-2068"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of the 20S proteasome as a possible strategy to counteract amylin oligomerization in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108157"}}